Richard B. Hancock

2021

In 2021, Richard B. Hancock earned a total compensation of $926.2K as Former Interim President and Chief Executive Officer at Peregrine Pharmaceuticals, a 20% increase compared to previous year.

Compensation breakdown

Bonus$123,730
Option Awards$455,084
Salary$148,923
Stock Awards$194,982
Other$3,509
Total$926,201

Hancock received $455.1K in option awards, accounting for 49% of the total pay in 2021.

Hancock also received $123.7K in bonus, $148.9K in salary, $195K in stock awards and $3.5K in other compensation.

Rankings

In 2021, Richard B. Hancock's compensation ranked 9,026th out of 12,405 executives tracked by ExecPay. In other words, Hancock earned more than 27.2% of executives.

ClassificationRankingPercentile
All
9,026
out of 12,405
27th
Division
Manufacturing
4,006
out of 5,494
27th
Major group
Chemicals And Allied Products
1,759
out of 2,369
26th
Industry group
Drugs
1,564
out of 2,090
25th
Industry
Pharmaceutical Preparations
1,164
out of 1,537
24th

Pay ratio

Richard B. Hancock's Pay$926,201
Median Employee's Pay$104,222
Pay Ratio

9

to 1

In 2021, the annual total compensation of Richard B. Hancock was $926,201.

The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,222.

The ratio of Richard B. Hancock's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on August 27, 2021.

Hancock's colleagues

We found three more compensation records of executives who worked with Richard B. Hancock at Peregrine Pharmaceuticals in 2021.

2021

Nicholas Green

Peregrine Pharmaceuticals

Chief Executive Officer

2021

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

2021

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

News

You may also like